The global demand for Rheumatoid Arthritis Diagnostic Tests Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Rheumatoid arthritis diagnostic tests are a series of tests conducted to determine the cause of weakened tendons, inflammatory joints, and ligaments, typical symptoms of rheumatoid arthritis (RA). In this autoimmune disorder, the body's immune system is attacked by the healthy cells inside the joints. Blood tests, imaging studies, and physical examination are used in unison to determine the cause of the inflammation. A set of blood tests are conducted to determine specific biomarkers like Rheumatoid factor (RF), Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and Complete blood count (CBC), Antinuclear Antibody (ANA), Anti-Cyclic Citrullinated Peptide to determine the cause of inflammation. If not diagnosed early, RA can be very aggressive and can lead to systemic complications and health issues.
The high rate of people affected by autoimmune disorders like RA is the principal facilitator for the RA diagnostic tests market's growth. The high prevalence of RA among the growing geriatric population will further propel the market growth. Government and private insurance companies providing reimbursement for the treatment of RA will be a market booster. Continued R & D of biomarker-based diagnostic tests and commercialization of reliable, cost-effective test kits will create lucrative opportunities for this market's growth. The availability of a broad range of test kits to diagnose the inflammation will support market growth. The major roadblock affecting this market is the limited sensitivity and concreteness of the test kits in diagnosis.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of rheumatoid arthritis diagnostic tests.
The entire rheumatoid arthritis diagnostic tests market has been sub-categorized into test type and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Test Type
By End User
- Serology Test
- Erythrocyte Sedimentation Rate (ESR)
- Rheumatoid Factor (RF)
- Anti-cyclic Citrullinated Peptide (anti-CCP)
- Antinuclear Antibody (ANA)
- Uric Acid
- Other Tests
- Monitoring RA Treatment Efficiency Tests
- Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test
- Diagnostic Laboratories
- Private Laboratories
- Public Laboratories
- Ambulatory Surgical Centers
This section covers regional segmentation which accentuates on current and future demand for rheumatoid arthritis diagnostic tests market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Rheumatoid Arthritis Diagnostic Tests Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the rheumatoid arthritis diagnostic tests market include Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.